| Subclinical thyroid disease: scientific review and guidelines for diagnosis and management MI Surks, E Ortiz, GH Daniels, CT Sawin, NF Col, RH Cobin, JA Franklyn, ... Jama 291 (2), 228-238, 2004 | 3073 | 2004 |
| Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement J Jonklaas, AC Bianco, AJ Bauer, KD Burman, AR Cappola, FS Celi, ... thyroid 24 (12), 1670-1751, 2014 | 2062* | 2014 |
| Alterations in thyroid function in patients with systemic illness: the “euthyroid sick syndrome” L Wartofsky, KD Burman Endocrine reviews 3 (2), 164-217, 1982 | 1350 | 1982 |
| American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer RC Smallridge, KB Ain, SL Asa, KC Bible, JD Brierley, KD Burman, ... Thyroid 22 (11), 1104-1139, 2012 | 777 | 2012 |
| Thyrotoxicosis and thyroid storm B Nayak, K Burman Endocrinology and Metabolism Clinics 35 (4), 663-686, 2006 | 486 | 2006 |
| Performance of a multigene genomic classifier in thyroid nodules with indeterminate cytology: a prospective blinded multicenter study DL Steward, SE Carty, RS Sippel, SP Yang, JA Sosa, JA Sipos, JJ Figge, ... JAMA oncology 5 (2), 204-212, 2019 | 437 | 2019 |
| A 2011 survey of clinical practice patterns in the management of Graves' disease HB Burch, KD Burman, DS Cooper The Journal of Clinical Endocrinology & Metabolism 97 (12), 4549-4558, 2012 | 414 | 2012 |
| Overexpression and overactivation of Akt in thyroid carcinoma MD Ringel, N Hayre, J Saito, B Saunier, F Schuppert, H Burch, V Bernet, ... Cancer research 61 (16), 6105-6111, 2001 | 385 | 2001 |
| Endocrine function in human obesity AR Glass, KD Burman, WT Dahms, TM Boehm Metabolism 30 (1), 89-104, 1981 | 326 | 1981 |
| Subclinical thyroid disease MI Surks, E Ocampo The American journal of medicine 100 (2), 217-223, 1996 | 317 | 1996 |
| Immune mechanisms in Graves' disease KD Burman, JR Baker Jr Endocrine reviews 6 (2), 183-232, 1985 | 314 | 1985 |
| Akt activation and localisation correlate with tumour invasion and oncogene expression in thyroid cancer V Vasko, M Saji, E Hardy, M Kruhlak, A Larin, V Savchenko, M Miyakawa, ... Journal of medical genetics 41 (3), 161-170, 2004 | 278 | 2004 |
| Anaplastic thyroid cancer RL Neff, WB Farrar, RT Kloos, KD Burman Endocrinology and metabolism clinics of North America 37 (2), 525-538, 2008 | 263 | 2008 |
| Acute bacterial suppurative thyroiditis: a clinical review and expert opinion JE Paes, KD Burman, J Cohen, J Franklyn, CR McHenry, S Shoham, ... Thyroid 20 (3), 247-255, 2010 | 262 | 2010 |
| Hyperthyroid heart disease BM Fadel, S Ellahham, J Lindsay Jr, MD Ringel, L Wartofsky, KD Burman Clinical cardiology 23 (6), 402-408, 2000 | 260 | 2000 |
| Metastin receptor is overexpressed in papillary thyroid cancer and activates MAP kinase in thyroid cancer cells MD Ringel, E Hardy, VJ Bernet, HB Burch, F Schuppert, KD Burman, ... The Journal of Clinical Endocrinology & Metabolism 87 (5), 2399-2402, 2002 | 237 | 2002 |
| A 2013 European survey of clinical practice patterns in the management of Graves' disease L Bartalena, HB Burch, KD Burman, GJ Kahaly Clinical endocrinology 84 (1), 115-120, 2016 | 232 | 2016 |
| Fine needle aspiration of thyroid nodules. Determinants of insufficiency rate and malignancy yield at thyroidectomy. HB Burch, KD Burman, HL Reed, L Buckner, T Raber, JL Ownbey Acta cytologica 40 (6), 1176-1183, 1996 | 225 | 1996 |
| Therapeutic advances in anaplastic thyroid cancer: a current perspective S Saini, K Tulla, AV Maker, KD Burman, BS Prabhakar Molecular cancer 17, 1-14, 2018 | 218 | 2018 |
| Spontaneous normalization of thyrotropin concentrations in patients with subclinical hypothyroidism JJ Díez, P Iglesias, KD Burman The Journal of Clinical Endocrinology & Metabolism 90 (7), 4124-4127, 2005 | 212 | 2005 |
